BR112016006426A2 - método de tratamento de cicatrizes cutâneas atróficas - Google Patents
método de tratamento de cicatrizes cutâneas atróficasInfo
- Publication number
- BR112016006426A2 BR112016006426A2 BR112016006426A BR112016006426A BR112016006426A2 BR 112016006426 A2 BR112016006426 A2 BR 112016006426A2 BR 112016006426 A BR112016006426 A BR 112016006426A BR 112016006426 A BR112016006426 A BR 112016006426A BR 112016006426 A2 BR112016006426 A2 BR 112016006426A2
- Authority
- BR
- Brazil
- Prior art keywords
- skin scars
- treating atrophic
- atrophic skin
- treating
- pgf
- Prior art date
Links
- 231100000241 scar Toxicity 0.000 title abstract 3
- 208000032544 Cicatrix Diseases 0.000 title abstract 2
- 206010040799 Skin atrophy Diseases 0.000 title abstract 2
- 230000037387 scars Effects 0.000 title abstract 2
- PXGPLTODNUVGFL-BRIYLRKRSA-N (E,Z)-(1R,2R,3R,5S)-7-(3,5-Dihydroxy-2-((3S)-(3-hydroxy-1-octenyl))cyclopentyl)-5-heptenoic acid Chemical compound CCCCC[C@H](O)C=C[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=CCCCC(O)=O PXGPLTODNUVGFL-BRIYLRKRSA-N 0.000 abstract 1
- PXGPLTODNUVGFL-UHFFFAOYSA-N prostaglandin F2alpha Natural products CCCCCC(O)C=CC1C(O)CC(O)C1CC=CCCCC(O)=O PXGPLTODNUVGFL-UHFFFAOYSA-N 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Dispersion Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361960740P | 2013-09-26 | 2013-09-26 | |
| PCT/IB2014/002746 WO2015044788A1 (en) | 2013-09-26 | 2014-09-26 | Prostaglandin f2alpha and analogues thereof for treating atrophic cutaneous scarring |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112016006426A2 true BR112016006426A2 (pt) | 2017-08-01 |
Family
ID=52282772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112016006426A BR112016006426A2 (pt) | 2013-09-26 | 2014-09-26 | método de tratamento de cicatrizes cutâneas atróficas |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10039770B2 (enExample) |
| EP (1) | EP3049088B1 (enExample) |
| JP (1) | JP6453318B2 (enExample) |
| KR (1) | KR102221499B1 (enExample) |
| CN (1) | CN105658221B (enExample) |
| AU (1) | AU2014326298B2 (enExample) |
| BR (1) | BR112016006426A2 (enExample) |
| CA (1) | CA2924460A1 (enExample) |
| MX (1) | MX374476B (enExample) |
| RU (1) | RU2690183C2 (enExample) |
| WO (1) | WO2015044788A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6659819B2 (ja) * | 2015-07-09 | 2020-03-04 | ガルデルマ・ソシエテ・アノニム | 化学療法に関連する脱毛の軽減方法 |
| CN106929477B (zh) * | 2017-03-20 | 2020-01-10 | 江南大学 | 一株抗前列腺素F2α的特异性单克隆抗体杂交瘤细胞株WXX-2及其应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3278447A (en) | 1963-12-02 | 1966-10-11 | Cloro Bac Products Inc | Process for stabilizing chlorine dioxide solution |
| CA2003198C (en) | 1988-11-29 | 1995-03-21 | Anthony J. Dziabo, Jr. | Aqueous ophthalmic solutions and method for preserving same |
| US5736165A (en) | 1993-05-25 | 1998-04-07 | Allergan | In-the-eye use of chlorine dioxide-containing compositions |
| US6194415B1 (en) | 1995-06-28 | 2001-02-27 | Allergan Sales, Inc. | Method of using (2-imidazolin-2-ylamino) quinoxoalines in treating neural injury |
| RU2195889C2 (ru) * | 1999-05-24 | 2003-01-10 | Парамонов Борис Алексеевич | Способ дермабразии |
| US6468989B1 (en) | 2000-07-13 | 2002-10-22 | Dow Pharmaceutical Sciences | Gel compositions containing metronidazole |
| US6387383B1 (en) | 2000-08-03 | 2002-05-14 | Dow Pharmaceutical Sciences | Topical low-viscosity gel composition |
| US7405274B2 (en) * | 2003-06-04 | 2008-07-29 | Fibrogen, Inc. | Connective tissue growth factor antibodies |
| EP2278993A4 (en) * | 2008-05-16 | 2012-09-12 | Corthera Inc | METHOD FOR PROMOTING HEALING |
| EP2389939A1 (en) * | 2010-05-28 | 2011-11-30 | Novagali Pharma S.A. | Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions |
| CN102031260A (zh) * | 2010-08-24 | 2011-04-27 | 苏州圣诺生物医药技术有限公司 | 促进皮肤伤口无疤痕愈合的siRNA及应用 |
| EP3178465A1 (en) * | 2010-12-06 | 2017-06-14 | Follica, Inc. | Methods for treating baldness and promoting hair growth |
| AU2012212481A1 (en) * | 2011-01-31 | 2013-08-22 | Allergan, Inc. | Method of enhancing hair growth |
| US20120251613A1 (en) * | 2011-03-29 | 2012-10-04 | Agila Specialities Pvt. Ltd. | Method for treating vitiligo with a prostaglandin analogue |
| WO2014179263A1 (en) * | 2013-04-30 | 2014-11-06 | Allergan, Inc. | Therapeutic agents |
-
2014
- 2014-09-26 BR BR112016006426A patent/BR112016006426A2/pt active Search and Examination
- 2014-09-26 WO PCT/IB2014/002746 patent/WO2015044788A1/en not_active Ceased
- 2014-09-26 CA CA2924460A patent/CA2924460A1/en not_active Abandoned
- 2014-09-26 US US15/021,789 patent/US10039770B2/en active Active
- 2014-09-26 MX MX2016003650A patent/MX374476B/es active IP Right Grant
- 2014-09-26 RU RU2016110925A patent/RU2690183C2/ru active
- 2014-09-26 EP EP14824091.4A patent/EP3049088B1/en active Active
- 2014-09-26 JP JP2016517505A patent/JP6453318B2/ja not_active Expired - Fee Related
- 2014-09-26 CN CN201480053306.1A patent/CN105658221B/zh not_active Expired - Fee Related
- 2014-09-26 KR KR1020167010897A patent/KR102221499B1/ko not_active Expired - Fee Related
- 2014-09-26 AU AU2014326298A patent/AU2014326298B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JP6453318B2 (ja) | 2019-01-16 |
| CN105658221A (zh) | 2016-06-08 |
| KR102221499B1 (ko) | 2021-03-02 |
| RU2016110925A (ru) | 2017-11-01 |
| AU2014326298A1 (en) | 2016-04-07 |
| CN105658221B (zh) | 2022-05-10 |
| MX2016003650A (es) | 2016-06-24 |
| WO2015044788A1 (en) | 2015-04-02 |
| US10039770B2 (en) | 2018-08-07 |
| EP3049088A1 (en) | 2016-08-03 |
| RU2016110925A3 (enExample) | 2018-07-13 |
| EP3049088B1 (en) | 2021-02-17 |
| RU2690183C2 (ru) | 2019-05-31 |
| KR20160055941A (ko) | 2016-05-18 |
| US20160228453A1 (en) | 2016-08-11 |
| AU2014326298B2 (en) | 2019-07-04 |
| MX374476B (es) | 2025-03-06 |
| JP2016531872A (ja) | 2016-10-13 |
| CA2924460A1 (en) | 2015-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2019009437A (es) | Tratamiento de mielosupresion. | |
| MX2022013172A (es) | Uso de un inhibidor de pcsk9 para tratar la hiperlipidemia. | |
| CO6940433A2 (es) | Compuestos inhibidores de metaloenzimas | |
| MX2015009058A (es) | Composiciones y metodos para tratar la inflamacion cronica y las enfermedades inflamatorias. | |
| MX366502B (es) | Composiciones y métodos para tratar heridas superficiales. | |
| MX374749B (es) | Terapia de combinacion que comprende un inhibidor de tor cinasa y un analogo de citidina para tratar cancer. | |
| BR102014006335B8 (pt) | Método para produzir uma população isolada de células-tronco de polpa dentária imaturas (idpscs) e uso | |
| BR112013020159A2 (pt) | método para inibir células tumorais de hamartoma | |
| MX376183B (es) | Composiciones para el tratamiento de rosacea. | |
| EA201592073A1 (ru) | Фармацевтические композиции, содержащие коллаген и гиалуронат натрия | |
| EA201690936A1 (ru) | Применение цистеамина и его производных для лечения митохондриальных заболеваний | |
| BR112013003846A2 (pt) | métodos de tratamento de celulite | |
| MX2016001686A (es) | Composicion para el tratamiento contra el envejecimiento de la piel. | |
| BR112016006426A2 (pt) | método de tratamento de cicatrizes cutâneas atróficas | |
| BR112017014552A2 (pt) | ?análogo de calcitonina, e, método para produzir uma diminuição nos triglicerídeos no fígado/redução de acúmulo de gordura no fígado? | |
| BR112015022265B8 (pt) | Composições pigmentadas para tratamento da pele | |
| EA201591185A1 (ru) | Применение пидотимода для лечения псориаза | |
| BR112015022275B8 (pt) | Composições pigmentadas para tratamento da pele | |
| BR112015020182A2 (pt) | uso cosmético de queuina ou de um precursor ou um derivado dessa como ingrediente ativo, uso de queuina ou um precursor ou um derivado dessa como ingrediente ativo, composição cosmética e processo de tratamento cosmético para prevenir e/ou tratar sinais de envelhecimento da pele e/ou anexos cutâneos | |
| CO7151515A2 (es) | Métodos para tratar deficiencia en la marcha y/o equilibrio en pacientes con esclerosis múltiple que utilizan una aminopiridina | |
| EA201690656A1 (ru) | Композиция для ухода за кожей тела и головы | |
| BR112015022279B8 (pt) | Composições pigmentadas para tratamento da pele | |
| EA201591184A1 (ru) | Применение пидотимода для лечения атопического дерматита | |
| BR112015022318B8 (pt) | Composições pigmentadas para tratamento da pele | |
| IN2012DE00313A (enExample) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B11D | Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time |